Quantifying the contribution of lipoprotein(a) to all apoB containing particles

Grundy, 2018, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines, Circulation, 139, e1046 Tsimikas, 2020, Lipoprotein(a) Reduction in Persons with Cardiovascular Disease, N Engl J Med, 382, 244, 10.1056/NEJMoa1905239 Yeang, 2021, Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements [published online ahead of print, 2021 Feb 24], J Lipid Res, 62 Zheng, 2022, Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol, J Am Heart Assoc, 11, 10.1161/JAHA.121.023136 Marcovina, 2016, Lipoprotein measurements for clinical application, J Lipid Res, 57, 526, 10.1194/jlr.R061648 Reyes-Soffer, 2021, Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the american heart association [published online ahead of print, 2021 Oct 14], Arterioscler Thromb Vasc Biol Maher, 2021, Global think tank on lipoprotein(a), J Clin Lipidol, 15, 387, 10.1016/j.jacl.2021.06.003 Knott, 1986, Complete protein sequence and identification of structural domains of human apolipoprotein B, Nature, 323, 734, 10.1038/323734a0 Elovson, 1988, Plasma very low density lipoproteins contain a single molecule of apolipoprotein B, J Lipid Res, 29, 1461, 10.1016/S0022-2275(20)38425-X Sniderman, 2019, Apolipoprotein B particles and cardiovascular disease: a narrative review, JAMA Cardiol, 4, 1287, 10.1001/jamacardio.2019.3780 Martin, 2013, Very large database of lipids: rationale and design, Clin Cardiol, 36, 641, 10.1002/clc.22214 Kulkarni, 2006, Cholesterol profile measurement by vertical auto profile method, Clin Lab Med, 26, 787, 10.1016/j.cll.2006.07.004 Joshi, 2016, Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson Heart and Framingham Offspring Cohort Studies, J Am Heart Assoc, 5, 10.1161/JAHA.115.002765 Pallazola, 2019, Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type iii hyperlipoproteinemia), Arch Med Sci, 16, 993, 10.5114/aoms.2019.86972 Delatour, 2018, Comparability of lipoprotein particle number concentrations across ES-DMA, NMR, LC-MS/MS, immunonephelometry, and VAP: in search of a candidate reference measurement procedure for apoB and non-HDL-P standardization, Clin Chem, 64, 1485, 10.1373/clinchem.2018.288746 Marcovina, 1995, Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a), Clin Chem, 41, 246, 10.1093/clinchem/41.2.246 Boerwinkle, 1992, Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations, J Clin Invest, 90, 52, 10.1172/JCI115855 Kronenberg, 2016, Human genetics and the causal role of lipoprotein(a) for various diseases, Cardiovasc Drugs Ther, 30, 87, 10.1007/s10557-016-6648-3 Sacks, 1986, Effects of a low-fat diet on plasma lipoprotein levels, Arch Intern Med, 146, 1573, 10.1001/archinte.1986.00360200143023 Ference, 2019, Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease, JAMA, 321, 364, 10.1001/jama.2018.20045 Trinder, 2021, Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a), Cardiovasc Res, 117, 1245, 10.1093/cvr/cvab060 Albers, 2013, Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis intervention in metabolic syndrome with Low HDL/High triglyceride and impact on global health outcomes), J Am Coll Cardiol, 62, 1575, 10.1016/j.jacc.2013.06.051 Khera, 2014, Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin), Circulation, 129, 635, 10.1161/CIRCULATIONAHA.113.004406